Literature DB >> 8861401

Prediction of attrition from day hospital treatment in lower socioeconomic cocaine-dependent men.

A I Alterman1, J R McKay, F D Mulvaney, A T McLellan.   

Abstract

This study attempted to identify predictors of completion of a 27 h/week 4-week day hospital program for cocaine dependence. The research subjects were 95 lower socioeconomic, primarily African American male veterans. Of a wide range of predictor variables available at baseline, including sociodemographic and historical information, Addiction Severity Index data, psychiatric diagnoses, SCL-90 measures, and measures of craving and familial alcoholism, only the cocaine urine toxicology result and self report of days of cocaine use in the past 30 days (log transformed) were significant predictors. The urine toxicology result was the more powerful predictor with 73 percent with a negative urine completing treatment, as contrasted with 36 percent with a positive urine. Three additional measures obtained at the end of treatment week 1 further increased ability to predict treatment completion/attrition. Two of these measures were based on counsellor ratings and one was based on the patient's report of psychiatric treatment services received during the first treatment week. Thus, patients at high risk for dropout can be identified fairly early. Whether treatments can be adapted to retain such patients is an important question for the field.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8861401     DOI: 10.1016/0376-8716(95)01212-5

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  26 in total

Review 1.  Illusory predictors: Generalizability of findings in cocaine treatment retention research.

Authors:  Angela L Stotts; Marc E Mooney; Shelly L Sayre; Meredith Novy; Joy M Schmitz; John Grabowski
Journal:  Addict Behav       Date:  2007-05-03       Impact factor: 3.913

Review 2.  The road to recovery: where are we going and how do we get there? Empirically driven conclusions and future directions for service development and research.

Authors:  Alexandre B Laudet
Journal:  Subst Use Misuse       Date:  2008       Impact factor: 2.164

3.  The neurobiology of cognitive control in successful cocaine abstinence.

Authors:  Colm G Connolly; John J Foxe; Jay Nierenberg; Marina Shpaner; Hugh Garavan
Journal:  Drug Alcohol Depend       Date:  2011-08-31       Impact factor: 4.492

4.  Predictors of treatment retention for substance-dependent adults with co-occurring depression.

Authors:  Susan R Tate; Jennifer Mrnak-Meyer; Chris L Shriver; Joseph H Atkinson; Shannon K Robinson; Sandra A Brown
Journal:  Am J Addict       Date:  2011-05-31

5.  Emotion regulation promotes persistence in a residential substance abuse treatment.

Authors:  Christopher J Hopwood; Nick Schade; Alexis Matusiewicz; Stacey B Daughters; Carl W Lejuez
Journal:  Subst Use Misuse       Date:  2014-11-18       Impact factor: 2.164

6.  Depressive symptomatology and early attrition from intensive outpatient substance use treatment.

Authors:  Geoffrey M Curran; JoAnn E Kirchner; Mark Worley; Craig Rookey; Brenda M Booth
Journal:  J Behav Health Serv Res       Date:  2002-05       Impact factor: 1.505

7.  New medications for the treatment of cocaine dependence.

Authors:  Kyle M Kampman
Journal:  Psychiatry (Edgmont)       Date:  2005-12

8.  Predictors of treatment outcome in outpatient cocaine and alcohol dependence treatment.

Authors:  Jamshid Ahmadi; Kyle M Kampman; David M Oslin; Helen M Pettinati; Charles Dackis; Thorne Sparkman
Journal:  Am J Addict       Date:  2009 Jan-Feb

9.  A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence.

Authors:  Kyle M Kampman; Kevin G Lynch; Helen M Pettinati; Kelly Spratt; Michael R Wierzbicki; Charles Dackis; Charles P O'Brien
Journal:  Drug Alcohol Depend       Date:  2015-08-14       Impact factor: 4.492

10.  The search for medications to treat stimulant dependence.

Authors:  Kyle M Kampman
Journal:  Addict Sci Clin Pract       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.